Delivery Order SPE2DR25D3103-SPE2DR26F9Y08
- Not listed
- The Defense Logistics Agency (DLA) awarded a $1,867.46 delivery order to AmerisourceBergen Drug Corp for Cortifoam 10% Aerosol 15GM on December 15, 2025, with completion scheduled for December 16, 2025. This non-set-aside contract represents a firm fixed-price delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. AmerisourceBergen, a major pharmaceutical distributor...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $3,656.64 for the supply of 4561599390 CORTIFOAM 10% AEROSOL 15GM. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of July 26, 2023. The contract is a firm fixed-price delivery order and does not have a set-aside designation, indicating it was awarded through full and open competition. Amerisourcebergen Drug...
- The Defense Logistics Agency awarded a delivery order valued at $1,217.64 to AmerisourceBergen Drug Corp for Proctofoam-HC 1%-1% Foam in a 10-gram quantity. This is a firm fixed-price, non-set-aside contract awarded on January 9, 2026, with an ultimate completion date of January 12, 2026. The place of performance is located in Conshohocken, Pennsylvania, which serves as the company's corporate headquarters. This delivery order represents a task order issued under AmerisourceBergen's larger...
- The Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation, a firm fixed price delivery order contract valued at $2,231.42 to provide PROCTOFOAM-HC 1%-1% FOAM 10GM. The contract has a completion date of February 22, 2024 and was awarded on February 21, 2024. Amerisourcebergen Drug Corp, through its Corporate Office division located in Conshohocken, Pennsylvania, is the prime contractor on...
- The Defense Logistics Agency (DLA) awarded a $1,077.91 delivery order to AmerisourceBergen Drug Corp for PROCTOFOAM-HC 1%-1% Foam in a 10-gram quantity, with an ultimate completion date of May 7, 2025. This is a firm fixed price, non-set-aside delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The product is being delivered to Conshohocken, Pennsylvania, where...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $10,351.14 on July 21, 2025, for the supply of Proctofoam 10GM by the Defense Logistics Agency's Medical Supply Chain, a defense-focused federal agency. This firm fixed-price, competitively awarded delivery order is scheduled for completion by July 22, 2025, and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $1,741.18 delivery order to AmerisourceBergen Drug Corp for Proctofoam-HC 1%-1% Foam in a 10-gram unit. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of December 18, 2025. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. Performance will occur at...
- The Defense Logistics Agency awarded a $1,014.70 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Proctofoam-HC 1%-1% Foam in a 10-gram unit on December 19, 2025, with an ultimate completion date of December 22, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. The award carried no set-aside designation...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a competitively procured delivery order valued at $3,213.77 by the Defense Logistics Agency's Medical Supply Chain for Proctofoam 10GM 1S, a pharmaceutical product. The contract was awarded on June 3, 2025, with an ultimate completion date of the same date, indicating a brief delivery timeline. As a child delivery order under a larger indefinite delivery contract vehicle, this award represents a discrete...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order by the Defense Logistics Agency (DLA) for Proctofoam-HC 1%-1% foam in a 10-gram formulation. The contract, awarded on December 17, 2025, carries a ceiling value of $2,029.40 and represents a firm fixed price delivery order under a larger indefinite delivery contract vehicle. This award was competitively procured with no set-aside designation, and...
- SPE2DR25D3103Indefinite Delivery Contract
- SPE2DR25D3103-SPE2DR26F9Y08Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,692.54 to AmerisourceBergen Drug Corp for Cortifoam 10% Aerosol 15GM, a pharmaceutical product for military medical supply needs. The award was issued on January 15, 2026, with an ultimate completion date of January 16, 2026, and utilized firm fixed-price pricing with no set-aside designation. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is a child contract executed under a larger Indefinite Delivery Contract (IDC) vehicle with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 through December 2026. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc. (doing business as AmerisourceBergen), is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement. The company supplies a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, including brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The prime IDC with DLA enables the company to serve the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems, with the company consistently winning competitively awarded contracts across a diverse portfolio of medical product deliveries.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 1/14/26 |